Cite
MLA Citation
Huey‐Huey Chua et al.. “RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma.” Hepatology, vol. 62, no. 5, n.d., pp. 1480–1496. http://access.bl.uk/ark:/81055/vdc_100026688380.0x00003a